These include two antidepressants: fluoxetine (Prozac, Sarafem, and generic) and fluvoxamine; three anti-fungal drugs: fluconazole, ketoconazole, voriconazole; the blood thinner, ticlopidine; the epilepsy drug, felbamate; and the HIV drug, etravirine. ❋ Unknown (2009)
These include two antidepressants: fluoxetine Prozac, Sarafem, and generic and fluvoxamine; three anti-fungal drugs: fluconazole, ketoconazole, voriconazole; the blood thinner, ticlopidine; the epilepsy drug, felbamate; and the HIV drug, etravirine. ❋ Unknown (2009)
Coadministration with the following is not recommended: nevirapine or salmeterol; other protease inhibitors, fluticasone propionate, or voriconazole when REYATAZ ® atazanavir sulfate is given with ritonavir; buprenorphine or bosentan when REYATAZ is given without ritonavir; proton-pump inhibitors or efavirenz in treatment-experienced patients; and colchicine in patients with renal or hepatic impairment.
VFEND voriconazole IV/Oral is the only broad-spectrum IV/oral triazole antifungal medication specifically indicated for the first-line treatment of both mould and yeast infections.
Vfend® (voriconazole) should not be taken with REYATAZ® (atazanavir sulfate) and Norvir ❋ Unknown (2010)
Do evenly buy sporanox drugs easier than 2 hallucinations per voriconazole or 5 methods per week. ❋ Unknown (2010)
Our results suggest that voriconazole is more effective than fluconazole ❋ U Gergis (2010)
The primary goal of this phase III study is to demonstrate statistical non-inferiority of isavuconazole versus the comparator, current standard - of-care voriconazole in the treatment of invasiveAspergillus infections. ❋ Unknown (2010)
Elevated bacteriologic voriconazole microorganisms imply and aspiration of irregular sputum has published reported. ❋ Unknown (2010)
Initially, all patients were treated with the anti-fungal medication voriconazole, but later the antibiotics vancomycin and ciprofloxacin were added. ❋ Unknown (2010)
In 2011, we look forward to monetizing or continuing to monetize several opportunities resulting from prior settlements such as Minocycline ER, voriconazole, letrozole and Venlafaxine ER. ❋ Unknown (2010)
A recent study suggests that the benefit is uncertain for patients undergoing treatment in HEPA filtered environments and who are also receiving antimicrobial prophylaxis with levofloxacin and valacyclovir plus itraconazole, voriconazole, or liposomal amphotericin-B. ❋ Unknown (2009)
- Company receives clearance to add voriconazole to its YeastOne (R) susceptibility plate for in vitro diagnostics; plate now includes four FDA-cleared antifungal agents - New Research-Use-Only Sensititre (R) ❋ Unknown (2009)
Quinidex® and others; Revatio® (sildenafil) only when used for the treatment of pulmonary arterial hypertension; Rythmol® (propafenone); Tambocor® (flecainide); Uroxatral® (alfuzosin hydrochloride); Vascor® (bepridil); Versed® (oral midazolam); and Vfend® (voriconazole). ❋ Unknown (2010)
/kg/day of prednisone or equivalent; when the analysis was restricted to these patients, the hazard ratio (0.39; 95 % confidence interval: 0. 08-1.86) was consistent with a protective effect of voriconazole compared with fluconazole ❋ U Gergis (2010)
(voriconazole) due to a contraindication with efavirenz. ❋ Unknown (2009)
PFE - News) today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND ® (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis (IA), a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.
